Drug Delivery Devices Market Outlook in Australia to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction

GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Australia to 2016 - Inhalation Systems, Infusion Systems and Others” provides key market data on the Australia Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories – Inhalation Systems, Needle Free Injections and Infusion Systems. Segments include Dry Powder Inhaler Devices, Metered Dose Inhaler Devices, Infusion Disposable Sets and Others. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Market size and company share data for Drug Delivery Devices market categories – Inhalation Systems, Needle Free Injections and Infusion Systems.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016. Segments include Dry Powder Inhaler Devices, Metered Dose Inhaler Devices, Infusion Disposable Sets and Others.
- 2009 company shares and distribution shares data for each of the three market categories.
- Global corporate-level profiles of key companies operating within the Australia Drug Delivery Devices market.
- Key players covered include GlaxoSmithKline plc, AstraZeneca International plc, Boehringer Ingelheim GmbH, Sepracor Inc., CareFusion Corporation and others.

Highlights

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Explore investment opportunites in the market.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Report Highlights
GlaxoSmithKline plc
AstraZeneca PLC
3M Health Care
Baxter International Inc.
Boehringer Ingelheim GmbH
Fresenius Kabi AG
Novartis Medical Nutrition
Smiths Medical
B. Braun Melsungen AG
Cardinal Health, Inc.
Hospira, Inc.
Terumo Corporation
JMS CO., LTD.
NIPRO CORPORATION
CareFusion Corporation
[Studien Infos ausblenden]

TABLE OF CONTENTS

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 What is This Report About? 8
3 Drug Delivery Devices in Australia 9
3.1 Drug Delivery Devices, Market Segmentation 9
3.2 Drug Delivery Devices, Australia, Overall Revenue ($m), 2002-2016 10
3.3 Drug Delivery Devices Market, Australia, Revenue Mix ($m), 2009 11
3.4 Drug Delivery Devices Market, Australia, Category Contribution (%), 2009 12
3.5 Drug Delivery Devices, Australia, Category Volume (Units), 2002-2016 19
3.6 Drug Delivery Devices, Australia, Company Share (2008-2009) 23
4 Infusion Systems in Australia 25
4.1 Infusion Systems, Market Segmentation 25
4.2 Infusion Systems Market, Australia, Revenue Mix ($m), 2009 26
4.3 Infusion Systems Market, Australia, Segment Contribution (%), 2009 27
4.4 Infusion Systems Overall Revenue (2002-2016) 28
4.5 Infusion Systems Overall Volume (2002-2016) 32
4.6 Infusion Systems Average Price (2002-2016) 36
4.7 Infusion Systems Distribution Share (2008-2009) 37
4.8 Infusion Systems, Australia, Company Share (2008-2009) 38
5 Inhalation Systems in Australia 40
5.1 Inhalation Systems, Market Segmentation 40
5.2 Inhalation Systems Market, Australia, Revenue Mix ($m), 2009 41
5.3 Inhalation Systems Market, Australia, Segment Contribution (%), 2009 42
5.4 Inhalation Systems Overall Revenue (2002-2016) 43
5.5 Inhalation Systems Overall Volume (2002-2016) 47
5.6 Inhalation Systems Average Price (2002-2016) 51
5.7 Inhalation Systems Distribution Share (2008-2009) 52
5.8 Inhalation Systems, Australia, Company Share (2008-2009) 53
6 Overview of Key Companies in Australia Drug Delivery Devices Market 55
6.1 GlaxoSmithKline plc 55
6.1.1 Company Overview 55
6.1.2 Share in the Australia Drug Delivery Devices Market 55
6.2 AstraZeneca PLC 56
6.2.1 Company Overview 56
6.2.2 Share in the Australia Drug Delivery Devices Market 56
6.3 3M Health Care 57
6.3.1 Company Overview 57
6.3.2 Share in the Australia Drug Delivery Devices Market 57
6.4 Baxter International Inc. 58
6.4.1 Company Overview 58
6.4.2 Share in the Australia Drug Delivery Devices Market 58
6.5 Boehringer Ingelheim GmbH 59
6.5.1 Company Overview 59
6.5.2 Share in the Australia Drug Delivery Devices Market 59
6.6 Fresenius Kabi AG 60
6.6.1 Company Overview 60
6.6.2 Share in the Australia Drug Delivery Devices Market 60
6.7 Novartis Medical Nutrition 61
6.7.1 Company Overview 61
6.8 Smiths Medical 61
6.8.1 Company Overview 61
6.9 B. Braun Melsungen AG 62
6.9.1 Company Overview 62
6.10 Cardinal Health, Inc. 62
6.10.1 Company Overview 62
6.11 Hospira, Inc. 62
6.11.1 Company Overview 62
6.12 Terumo Corporation 63
6.12.1 Company Overview 63
6.13 JMS CO., LTD. 63
6.13.1 Company Overview 63
6.14 NIPRO CORPORATION 64
6.14.1 Company Overview 64
6.15 CareFusion Corporation 64
6.15.1 Company Overview 64
7 Drug Delivery Devices Market Pipeline Products 65
8 Appendix 71
8.1 Definitions of Markets Covered in the Report 72
8.1.1 Drug Delivery Devices 72
8.2 Research Methodology 73
8.3 Secondary Research 73
8.4 Primary Research 74
8.5 Models 74
8.6 Forecasts 75
8.7 Expert Panels 75
8.8 GlobalData Consulting 75
8.9 Currency Conversion 76
8.10 Contact Us 76
8.11 Disclaimer 76
[Inhaltsverzeichnis ausblenden]

LIST OF TABLES

1.1 List of Tables
Table 1: Drug Delivery Devices, Australia, Overall Revenue ($m), 2002-2016 10
Table 2: Drug Delivery Devices Market, Australia, Category Contribution (%), 2009 12
Table 3: Drug Delivery Devices, Australia, Cross-Segment Analysis, 2002-2016 14
Table 4: Drug Delivery Devices, Australia, Overall Revenue ($m), Historic, 2002-2009 16
Table 5: Drug Delivery Devices, Australia, Overall Revenue ($m), Forecast, 2009-2016 18
Table 6: Drug Delivery Devices, Australia, Category Volume (Units), 2002-2016 19
Table 7: Drug Delivery Devices, Australia, Category Volume (Units), Historic, 2002-2009 21
Table 8: Drug Delivery Devices, Australia, Category Volume (Units), Forecast, 2009-2016 22
Table 9: Drug Delivery Devices, Australia, Company Share by Revenue ($m), 2008-2009 24
Table 10: Infusion Systems Market, Australia, Segment Contribution (%), 2009 27
Table 11: Infusion Systems, Australia, Revenue ($m) by Segment, Historic, 2002-2009 29
Table 12: Infusion Systems, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 31
Table 13: Infusion Systems, Australia, Volume (Units) by Segment, Historic, 2002-2009 33
Table 14: Infusion Systems, Australia, Volume (Units) by Segment, Forecast, 2009-2016 35
Table 15: Infusion Systems, Australia, Average Price ($), Historic, 2002-2009 36
Table 16: Infusion Systems, Australia, Average Price ($), Forecast, 2009-2016 36
Table 17: Infusion Systems, Australia, Distribution Share by Revenue ($m), 2008-2009 37
Table 18: Infusion Systems, Australia, Company Share by Revenue ($m), 2008-2009 39
Table 19: Inhalation Systems Market, Australia, Segment Contribution (%), 2009 42
Table 20: Inhalation Systems, Australia, Revenue ($m) by Segment, Historic, 2002-2009 44
Table 21: Inhalation Systems, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 46
Table 22: Inhalation Systems, Australia, Volume (Units) by Segment, Historic, 2002-2009 48
Table 23: Inhalation Systems, Australia, Volume (Units) by Segment, Forecast, 2009-2016 50
Table 24: Inhalation Systems, Australia, Average Price ($), Historic, 2002-2009 51
Table 25: Inhalation Systems, Australia, Average Price ($), Forecast, 2009-2016 51
Table 26: Inhalation Systems, Australia, Distribution Share by Revenue ($m), 2008-2009 52
Table 27: Inhalation Systems, Australia, Company Share by Revenue ($m), 2008-2009 54
Table 28: Drug Delivery Devices Market Pipeline Products 65
Table 29: USD to Local Currency, Australia, Average Actual Rate 2002-2009 76
LIST OF FIGURES

1.2 List of Figures
Figure 1: Drug Delivery Devices, Market Segmentation 9
Figure 2: Drug Delivery Devices, Australia, Overall Revenue ($m), 2002-2016 10
Figure 3: Drug Delivery Devices Market, Australia, Revenue Mix ($m), 2009 11
Figure 4: Drug Delivery Devices Market, Australia, Category Contribution (%), 2009 12
Figure 5: Drug Delivery Devices, Australia, Cross-Segment Analysis, 2002-2016 13
Figure 6: Drug Delivery Devices, Australia, Overall Revenue ($m), Historic, 2002-2009 15
Figure 7: Drug Delivery Devices, Australia, Overall Revenue ($m), Forecast, 2009-2016 17
Figure 8: Drug Delivery Devices, Australia, Category Volume (Units), 2002-2016 19
Figure 9: Drug Delivery Devices, Australia, Category Volume (Units), Historic, 2002-2009 20
Figure 10: Drug Delivery Devices, Australia, Category Volume (Units), Forecast, 2009-2016 22
Figure 11: Drug Delivery Devices, Australia, Company Share (%), 2009 23
Figure 12: Infusion Systems, Market Segmentation 25
Figure 13: Infusion Systems Market, Australia, Revenue Mix ($m), 2009 26
Figure 14: Infusion Systems Market, Australia, Segment Contribution (%), 2009 27
Figure 15: Infusion Systems, Australia, Revenue ($m) by Segment, Historic, 2002-2009 28
Figure 16: Infusion Systems, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 30
Figure 17: Infusion Systems, Australia, Volume (Units) by Segment, Historic, 2002-2009 32
Figure 18: Infusion Systems, Australia, Volume (Units) by Segment, Forecast, 2009-2016 34
Figure 19: Infusion Systems, Australia, Company Share (%), 2009 38
Figure 20: Inhalation Systems, Market Segmentation 40
Figure 21: Inhalation Systems Market, Australia, Revenue Mix ($m), 2009 41
Figure 22: Inhalation Systems Market, Australia, Segment Contribution (%), 2009 42
Figure 23: Inhalation Systems, Australia, Revenue ($m) by Segment, Historic, 2002-2009 43
Figure 24: Inhalation Systems, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 45
Figure 25: Inhalation Systems, Australia, Volume (Units) by Segment, Historic, 2002-2009 47
Figure 26: Inhalation Systems, Australia, Volume (Units) by Segment, Forecast, 2009-2016 49
Figure 27: Inhalation Systems, Australia, Company Share (%), 2009 53
Figure 28: GlaxoSmithKline plc, Company Share (%),Australia Drug Delivery Devices Market, 2009 55
Figure 29: AstraZeneca PLC, Company Share (%),Australia Drug Delivery Devices Market, 2009 56
Figure 30: 3M Health Care, Company Share (%),Australia Drug Delivery Devices Market, 2009 57
Figure 31: Baxter International Inc., Company Share (%),Australia Drug Delivery Devices Market, 2009 58
Figure 32: Boehringer Ingelheim GmbH, Company Share (%),Australia Drug Delivery Devices Market, 2009 59
Figure 33: Fresenius Kabi AG, Company Share (%),Australia Drug Delivery Devices Market, 2009 60
[Tabellenverzeichnis ausblenden]